Visby Medical Exhibits at 2022 IDSOG in Boston

For two great ways to learn about Visby rapid PCR, stop by table #6 or catch the breakfast panel discussion on Thursday, August 4 at 7am, all at Revere Hotel Boston Common in Boston, August 4-6.
Visby Medical to Exhibit at 2022 AACC in Chicago

2022 AACC will showcase the future of laboratory medicine, which includes Visby Medical rapid PCR for the point of care which can help ease lab backlogs.
Visby Connects with City and County Health Officials at NACCHO in Atlanta

Visby brings point-of-care PCR to the deep south with an appearance at NACCHO360.
Visby Medical Expands Series E Round to Over $135 Million

Visby Medical extends Series E round to include an additional $35 million, totaling more than $135 million raised.
Visby Reaffirms Support for Women’s Access to Healthcare

Visby Medical’s CEO reaffirms support for women’s healthcare access, announcing travel expense reimbursement for employees for out-of-state pregnancy-related care.
Visby Medical to Present Poster at the Julius Schacter Chlamydia Conference

Offering a high-quality scientific meeting covering all aspects in the field of chlamydia research, this symposium provides an excellent opportunity for specialists and trainees in sexual health, HIV medicine, public health, microbiology, epidemiology and behavioral science to share their ideas and experiences.
AACC selects Visby Medical as 2022 Disruptive Technology Award Finalist

AACC selects Visby Medical as a finalist for the 2022 Disruptive Technology Award for its handheld point-of-care PCR diagnostic technology.
Visby Medical Appoints Everett Cunningham to Board of Directors

Visby Medical today announced Everett Cunningham has been appointed to the company’s Board of Directors.
Respiratory Diseases – The Current Landscape

Respiratory diseases are a leading cause of death worldwide. Get an overview of the most common respiratory diseases, their causes, and treatments.
COVID-19, Influenza A, Influenza B, and Respiratory Syncytial Virus

COVID, Influenza A and B, and RSV may be similar in symptoms, but they need to be treated differently. Learn the difference here.